Strategic role for mitochondria in Alzheimer's disease and cancer

Antioxidants and Redox Signaling

Volumn 16, Issue 12, 2012, Pages 1476-1491

  Hedskog, Louise ^a   Zhang, Shouting ^a   Ankarcrona, Maria ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; APOPTOSIS REPRESSOR WITH CASPASE RECRUITMENT DOMAIN; CASPASE 10; CASPASE 2; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CASPASE ACTIVATED DEOXYRIBONUCLEASE; CYTOCHROME C; MITOCHONDRIAL DNA; PRESENILIN 1; PROTEIN BCL 2; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE OMI;

ALLELE; ALZHEIMER DISEASE; APOPTOSIS; ASTROCYTE; AUTOPHAGY; BREAST CANCER; CANCER CELL; CANCER SURVIVAL; CEREBROSPINAL FLUID; DNA FRAGMENTATION; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GLYCOLYSIS; HUMAN; HYPOXIA; LONG TERM DEPRESSION; MITOCHONDRION; NEOPLASM; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NEURITE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; THYROID CANCER; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; HUMANS; MITOCHONDRIA; NEOPLASMS; OXIDATIVE PHOSPHORYLATION;

EID: 84860124421     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4259     Document Type: Review

References (183)

1. Albrecht P, Schmitz M, Otto M, Hemmer B, Zerr I, Hartung HP, and Methner A. Free caspase activity in CSF of patients with dementia. J Neurol 256: 1561-1562, 2009.
2. Albrecht S, Bogdanovic N, Ghetti B, Winblad B, and Le-Blanc AC. Caspase-6 activation in familial Alzheimer disease brains carrying amyloid precursor protein or presenilin i or presenilin II mutations. J Neuropathol Exp Neurol 68: 1282-1293, 2009.
3. a. Alikhani N, Guo L, Yan S, Du H, Pinho CM, Chen JX, Glaser E, and Yan SS. Decreased proteolytic activity of the mitochondrial amyloid-b degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria. J Alzheimers Dis 2011 [Epub ahead of print]; PMID: 21750375.
4. Alves da Costa C, Sunyach C, Pardossi-Piquard R, Sevalle J, Vincent B, Boyer N, Kawarai T, Girardot N, St George-Hyslop P, and Checler F. Presenilin-dependent gammasecretase-mediated control of p53-associated cell death in Alzheimer's disease. J Neurosci 26: 6377-6385, 2006.
5. Anandatheerthavarada HK, Biswas G, Robin MA, and Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161: 41-54, 2003. (Pubitemid 36459078)
6. Area-Gomez E, de Groof AJ, Boldogh I, Bird TD, Gibson GE, Koehler CM, Yu WH, Duff KE, Yaffe MP, Pon LA, and Schon EA. Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. Am J Pathol 175: 1810-1816, 2009.
7. Autret A and Martin SJ. Emerging role for members of the Bcl-2 family in mitochondrial morphogenesis. Mol Cell 36: 355-363, 2009.
8. Baloyannis SJ. Mitochondrial alterations in Alzheimer's disease. J Alzheimers Dis 9: 119-126, 2006. (Pubitemid 44088243)
9. Bandelt HJ, Salas A, and Bravi CM. What is a 'novel' mtDNA mutation-And does 'novelty' really matter? J Hum Genet 51: 1073-1082, 2006. (Pubitemid 44800726)
10. Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Graber S, Kovacs I, Lee WD, Waggoner J, Cui J, White AD, Bossy B, Martinou JC, Youle RJ, Lipton SA, Ellisman MH, Perkins GA, and Bossy-Wetzel E. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 25: 3900-3911, 2006. (Pubitemid 44300275)
11. Baysal B. Mitochondria: More than mitochondrial DNA in cancer. PLoS Med 3: e156; author reply e166, 2006.
12. Bedard K and Krause KH. The NOX family of ROSgenerating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87: 245-313, 2007. (Pubitemid 46209993)
13. Benard G, Bellance N, James D, Parrone P, Fernandez H, Letellier T, and Rossignol R. Mitochondrial bioenergetics and structural network organization. J Cell Sci 120: 838-848, 2007. (Pubitemid 46523485)
14. Bigl M, Bruckner MK, Arendt T, Bigl V, and Eschrich K. Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease. J Neural Transm 106: 499-511, 1999. (Pubitemid 29273888)
15. Bossy B, Petrilli A, Klinglmayr E, Chen J, Lutz-Meindl U, Knott AB, Masliah E, Schwarzenbacher R, and Bossy-Wetzel E. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease. J Alzheimers Dis 20 Suppl 2: S513-526, 2010.
16. Bredesen DE. Neurodegenerative disease and cancer: Two sides of a coin? Hosp Pract (Minneap) 36: 39-42, 45, 2001.
17. Brown WM, George M, Jr., and Wilson AC. Rapid evolution of animal mitochondrial DNA. Proc Natl Acad Sci USA 76: 1967-1971, 1979. (Pubitemid 9207037)
18. Bubber P, Haroutunian V, Fisch G, Blass JP, and Gibson GE. Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications. Ann Neurol 57: 695-703, 2005. (Pubitemid 40628858)
19. Buchwald P, Krummeck G, and Rodel G. Immunological identification of yeast SCO1 protein as a component of the inner mitochondrial membrane. Mol Gen Genet 229: 413-420, 1991.
20. Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, Garcia-Quintanilla A, Cano J, Brundin P, Englund E, Venero JL, and Joseph B. Caspase signalling controls microglia activation and neurotoxicity. Nature 472: 319-324, 2011.
21. Butterfield DA, Hardas SS, and Lange ML. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: Many pathways to neurodegeneration. J Alzheimers Dis 20: 369-393, 2010.
22. Butterfield DA and Lange ML. Multifunctional roles of enolase in Alzheimer's disease brain: Beyond altered glucose metabolism. J Neurochem 111: 915-933, 2009.
23. Canter JA, Kallianpur AR, Parl FF, and Millikan RC. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 65: 8028-8033, 2005. (Pubitemid 41297284)
24. Cardoso SM, Proenca MT, Santos S, Santana I, and Oliveira CR. Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol Aging 25: 105-110, 2004. (Pubitemid 37522198)
25. Carew JS and Huang P. Mitochondrial defects in cancer. Mol Cancer 1: 9, 2002.
26. Carretero J, Obrador E, Pellicer JA, Pascual A, and Estrela JM. Mitochondrial glutathione depletion by glutamine in growing tumor cells. Free Radic Biol Med 29: 913-923, 2000.
27. Carrieri G, Bonafe M, De Luca M, Rose G, Varcasia O, Bruni A, Maletta R, Nacmias B, Sorbi S, Corsonello F, Feraco E, Andreev KF, Yashin AI, Franceschi C, and De Benedictis G. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Hum Genet 108: 194-198, 2001. (Pubitemid 32293664)
28. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, Xu HW, Stern D, McKhann G, and Yan SD. Mitochondrial Abeta: A potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 19: 2040-2041, 2005. (Pubitemid 41759758)
29. Chen H and Chan DC. Mitochondrial dynamics-Fusion, fission, movement, and mitophagy in neurodegenerative diseases. Hum Mol Genet 18: R169-176, 2009.
30. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, and Lipton SA. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324: 102-105, 2009.
31. Cho DH, Nakamura T, and Lipton SA. Mitochondrial dynamics in cell death and neurodegeneration. Cell Mol Life Sci 67: 3435-3447, 2010.
32. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, and Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452: 230-233, 2008. (Pubitemid 351380249)
33. Compton S, Kim C, Griner NB, Potluri P, Scheffler IE, Sen S, Jerry DJ, Schneider S, and Yadava N. Mitochondrial dysfunction impairs tumor suppressor p53 expression/function. J Biol Chem 286: 20297-20312, 2011.
34. Crouch PJ, Blake R, Duce JA, Ciccotosto GD, Li QX, Barnham KJ, Curtain CC, Cherny RA, Cappai R, Dyrks T, Masters CL, and Trounce IA. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J Neurosci 25: 672-679, 2005.
35. Currais A, Hortobagyi T, and Soriano S. The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease. Aging (Albany NY) 1: 363-371, 2009.
36. Czarnecka AM, Golik P, and Bartnik E. Mitochondrial DNA mutations in human neoplasia. J Appl Genet 47: 67-78, 2006. (Pubitemid 43232163)
37. Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19: 1-11, 1999. (Pubitemid 29018404)
38. Dang CV. The interplay between MYC and HIF in the Warburg effect. Ernst Schering Found Symp Proc: 35-53, 2007.
39. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 24: 68-72, 1999. (Pubitemid 29346576)
40. Darvishi K, Sharma S, Bhat AK, Rai E, and Bamezai RN. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett 249: 249-255, 2007. (Pubitemid 46452933)
41. de Calignon A, Fox LM, Pitstick R, Carlson GA, Bacskai BJ, Spires-Jones TL, and Hyman BT. Caspase activation precedes and leads to tangles. Nature 464: 1201-1204, 2010.
42. De Gasperi R, Sosa MA, Dracheva S, and Elder GA. Presenilin-1 regulates induction of hypoxia inducible factor-1alpha: Altered activation by a mutation associated with familial Alzheimer's disease. Mol Neurodegener 5: 38, 2010.
43. Don AS and Hogg PJ. Mitochondria as cancer drug targets. Trends Mol Med 10: 372-378, 2004. (Pubitemid 39061138)
44. Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, and Yan SD. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 14: 1097-1105, 2008.
45. Du H, Guo L, Zhang W, Rydzewska M, and Yan S. Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model. Neurobiol Aging 32: 398-406, 2009.
46. Edgar D, Shabalina I, Camara Y, Wredenberg A, Calvaruso MA, Nijtmans L, Nedergaard J, Cannon B, Larsson NG, and Trifunovic A. Random point mutations with major effects on protein-coding genes are the driving force behind premature aging in mtDNA mutator mice. Cell Metab 10: 131-138, 2009.
47. Ekstrand MI, Terzioglu M, Galter D, Zhu S, Hofstetter C, Lindqvist E, Thams S, Bergstrand A, Hansson FS, Trifunovic A, Hoffer B, Cullheim S, Mohammed AH, Olson L, and Larsson NG. Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci USA 104: 1325-1330, 2007. (Pubitemid 46184003)
48. Falkevall A, Alikhani N, Bhushan S, Pavlov PF, Busch K, Johnson KA, Eneqvist T, Tjernberg L, Ankarcrona M, and Glaser E. Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP. J Biol Chem 281: 29096-29104, 2006. (Pubitemid 44507053)
49. Fantin VR, St-Pierre J, and Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9: 425-434, 2006. (Pubitemid 43832190)
50. Fattoretti P, Balietti M, Casoli T, Giorgetti B, Di Stefano G, Bertoni-Freddari C, Lattanzio F, and Sensi SL. Decreased numeric density of succinic dehydrogenase-positive mitochondria in CA1 pyramidal neurons of 3xTg-AD mice. Rejuvenation Res 13: 144-147, 2010.
51. Frederikse PH, Garland D, Zigler JS, Jr., and Piatigorsky J. Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells. J Biol Chem 271: 10169-10174, 1996. (Pubitemid 26131580)
52. Gabuzda D, Busciglio J, Chen LB, Matsudaira P, and Yankner BA. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 269: 13623-13628, 1994. (Pubitemid 24206141)
53. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, and Cryns VL. Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA 100: 10032-10037, 2003. (Pubitemid 37087063)
54. Gilman CP and Mattson MP. Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility? Neuromolecular Med 2: 197-214, 2002. (Pubitemid 37012504)
55. Zornig M, Hueber A, Baum W, and Evan G. Apoptosis regulators and their role in tumorigenesis. Biochim Biophys Acta 1551: F1-37, 2001. (Pubitemid 32925236)
56. Gogvadze V, Zhivotovsky B, and Orrenius S. The Warburg effect and mitochondrial stability in cancer cells. Mol Aspects Med 31: 60-74, 2010.
57. Gonzalez FJ. Role of cytochromes P450 in chemical toxicity and oxidative stress: Studies with CYP2E1. Mutat Res 569: 101-110, 2005. (Pubitemid 39643260)
58. Granchi C, Roy S, Giacomelli C, Macchia M, Tuccinardi T, Martinelli A, Lanza M, Betti L, Giannaccini G, Lucacchini A, Funel N, Leon LG, Giovannetti E, Peters GJ, Palchaud-huri R, Calvaresi EC, Hergenrother PJ, and Minutolo F. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells. J Med Chem 54: 1599-1612, 2011.
59. Grandemange S, Herzig S, and Martinou JC. Mitochondrial dynamics and cancer. Semin Cancer Biol 19: 50-56, 2009.
60. Guix FX, Ill-Raga G, Bravo R, Nakaya T, de Fabritiis G, Coma M, Miscione GP, Villa-Freixa J, Suzuki T, Fernandez-Busquets X, Valverde MA, de Strooper B, and Munoz FJ. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation. Brain 132: 1335-1345, 2009.
61. Guo H, Albrecht S, Bourdeau M, Petzke T, Bergeron C, and LeBlanc AC. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. Am J Pathol 165: 523-531, 2004. (Pubitemid 38971382)
62. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325, 1992.
63. Han XJ, Tomizawa K, Fujimura A, Ohmori I, Nishiki T, Matsushita M, and Matsui H. Regulation of mitochondrial dynamics and neurodegenerative diseases. Acta Med Okayama 65: 1-10, 2011.
64. Hanahan D and Weinberg RA. The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
65. Hansson CA, Frykman S, Farmery MR, Tjernberg LO, Nilsberth C, Pursglove SE, Ito A, Winblad B, Cowburn RF, Thyberg J, and Ankarcrona M. Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J Biol Chem 279: 51654-51660, 2004. (Pubitemid 40017916)
66. Hansson Petersen CA, Alikhani N, Behbahani H, Wiehager B, Pavlov PF, Alafuzoff I, Leinonen V, Ito A, Winblad B, Glaser E, and Ankarcrona M. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci USA 105: 13145-13150, 2008.
67. Harrison R. Physiological roles of xanthine oxidoreductase. Drug Metab Rev 36: 363-375, 2004. (Pubitemid 38802492)
68. Hedskog L, Petersen CA, Svensson AI, Welander H, Tjernberg LO, Karlstrom H, and Ankarcrona M. Gammasecretase complexes containing caspase-cleaved presenilin-1 increaseintracellular Abeta42/Abeta40 ratio. J Cell Mol Med 15: 2150-2163, 2011.
69. Hidalgo C and Carrasco MA. Redox control of brain calcium in health and disease. Antioxid Redox Signal 14: 1203-1207, 2011.
70. Hussien R and Brooks GA. Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines. Physiol Genomics 43: 255-264, 2011.
71. Inzelberg R and Jankovic J. Are Parkinson disease patients protected from some but not all cancers? Neurology 69: 1542-1550, 2007. (Pubitemid 47537862)
72. Ishikawa K, Koshikawa N, Takenaga K, Nakada K,and Hayashi J. Reversible regulation of metastasis by ROSgenerating mtDNA mutations. Mitochondrion 8: 339-344, 2008.
73. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, and Hayashi J. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320: 661-664, 2008. (Pubitemid 351928347)
74. Izumi Y, Benz AM, Katsuki H, and Zorumski CF. Endogenous monocarboxylates sustain hippocampal synaptic function and morphological integrity during energy deprivation. J Neurosci 17: 9448-9457, 1997. (Pubitemid 28006389)
75. Izumi Y, Ishii K, Katsuki H, Benz AM, and Zorumski CF. beta-Hydroxybutyrate fuels synaptic function during development. Histological and physiological evidence in rat hippocampal slices. J Clin Invest 101: 1121-1132, 1998. (Pubitemid 28125291)
76. Khrapko K and Vijg J. Mitochondrial DNA mutations and aging: A case closed? Nat Genet 39: 445-446, 2007. (Pubitemid 46514762)
77. Kim JW, Tchernyshyov I, Semenza GL, and Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3: 177-185, 2006.
78. Kim TW, Pettingell WH, Jung YK, Kovacs DM, and Tanzi RE. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277: 373-376, 1997. (Pubitemid 27450710)
79. Kluck RM, Bossy-Wetzel E, Green DR, and Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-6, 1997. (Pubitemid 27097313)
80. Knott AB, Perkins G, Schwarzenbacher R, and Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9: 505-518, 2008. (Pubitemid 351873464)
81. Kondoh H, Lleonart ME, Gil J, Wang J, Degan P, Peters G, Martinez D, Carnero A, and Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res 65: 177-185, 2005. (Pubitemid 40070808)
82. Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu HY, Hyman BT, and Bacskai BJ. Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59: 214-225, 2008. (Pubitemid 352033686)
83. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, Morrow JD, Van Remmen H, Sedivy JM, Yamasoba T, Tanokura M, Weindruch R, Leeuwenburgh C, and Prolla TA. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309: 481-484, 2005. (Pubitemid 40994689)
84. Kuramitsu Y and Nakamura K. Proteomic analysis of cancer tissues: Shedding light on carcinogenesis and possible biomarkers. Proteomics 6: 5650-5661, 2006. (Pubitemid 44683228)
85. Kurochkin IV. Insulin-degrading enzyme: Embarking on amyloid destruction. Trends Biochem Sci 26: 421-425, 2001. (Pubitemid 32607483)
86. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, and Dang CV. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA 107: 2037-2042, 2010.
87. Lee HG, Casadesus G, Nunomura A, Zhu X, Castellani RJ, Richardson SL, Perry G, Felsher DW, Petersen RB, and Smith MA. The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol 174: 891-897, 2009.
88. Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, Uchiyama Y, Westaway D, Cuervo AM, and Nixon RA. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141: 1146-1158, 2010.
89. Levine AJ, Feng Z, Mak TW, You H, and Jin S. Coordination and communication between the p53 and IGF-1-AKTTOR signal transduction pathways. Genes Dev 20: 267-275, 2006. (Pubitemid 43200281)
90. Lewis HD, Leveridge M, Strack PR, Haldon CD, O'Neil J, Kim H, Madin A, Hannam JC, Look AT, Kohl N, Draetta G, Harrison T, Kerby JA, Shearman MS, and Beher D. Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling. Chem Biol 14: 209-219, 2007. (Pubitemid 46274429)
91. Li Z, Jo J, Jia JM, Lo SC, Whitcomb DJ, Jiao S, Cho K, and Sheng M. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 141: 859-871, 2010.
92. Lin MT, Simon DK, Ahn CH, Kim LM, and Beal MF. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum Mol Genet 11: 133-145, 2002. (Pubitemid 34157005)
93. Louneva N, Cohen JW, Han LY, Talbot K, Wilson RS, Bennett DA, Trojanowski JQ, and Arnold SE. Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease. Am J Pathol 173: 1488-1495, 2008.
94. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, and Wu H. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304: 448-452, 2004. (Pubitemid 38495942)
95. Ma L, Ohyagi Y, Miyoshi K, Sakae N, Motomura K, Taniwaki T, Furuya H, Takeda K, Tabira T, and Kira J. Increase in p53 protein levels by presenilin 1 gene mutations and its inhibition by secretase inhibitors. J Alzheimers Dis 16: 565-575, 2009.
96. Malik B, Currais A, Andres A, Towlson C, Pitsi D, Nunes A, Niblock M, Cooper J, Hortobagyi T, and Soriano S. Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain. Cell Cycle 7: 637-646, 2008. (Pubitemid 351499003)
97. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, and Reddy PH. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: Implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15: 1437-1449, 2006.
98. Mandavilli BS, Santos JH, and Van Houten B. Mitochondrial DNA repair and aging. Mutat Res 509: 127-151, 2002. (Pubitemid 35341457)
99. Mann DM, Jones D, Snowden JS, Neary D, and Hardy J. Pathological changes in the brain of a patient with familial Alzheimer's disease having a missense mutation at codon 717 in the amyloid precursor protein gene. Neurosci Lett 137: 225-228, 1992.
100. Martinez-Diez M, Santamaria G, Ortega AD, and Cuezva JM. Biogenesis and dynamics of mitochondria during the cell cycle: Significance of 3'UTRs. PLoS One 1: e107, 2006.
101. Martins RN, Harper CG, Stokes GB, and Masters CL. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J Neurochem 46: 1042-1045, 1986. (Pubitemid 16010948)
102. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, and Hwang PM. p53 regulates mitochondrial respiration. Science 312: 1650-1653, 2006. (Pubitemid 43902663)
103. Mattson MP, Keller JN, and Begley JG. Evidence for synaptic apoptosis. Exp Neurol 153: 35-48, 1998. (Pubitemid 28452295)
104. Mattson MP, Pedersen WA, Duan W, Culmsee C, and Camandola S. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Ann NY Acad Sci 893: 154-175, 1999. (Pubitemid 30038074)
105. Meng RD, Shelton CC, Li YM, Qin LX, Notterman D, Paty PB, and Schwartz GK. gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res 69: 573-582, 2009.
106. Mielke R, Schroder R, Fink GR, Kessler J, Herholz K, and Heiss WD. Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol 91: 174-179, 1996. (Pubitemid 26021405)
107. Mims MP, Hayes TG, Zheng S, Leal SM, Frolov A, Ittmann MM, Wheeler TM, and Prchal JT. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 66: 1880; author reply 1880-1881, 2006.
108. Misonou H, Morishima-Kawashima M, and Ihara Y. Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry 39: 6951-6959, 2000. (Pubitemid 30390389)
109. Moberg P, Stahl A, Bhushan S, Wright SJ, Eriksson A, Bruce BD, and Glaser E. Characterization of a novel zinc metalloprotease involved in degrading targeting peptides in mitochondria and chloroplasts. Plant J 36: 616-628, 2003. (Pubitemid 37496490)
110. Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, De Santi S, and de Leon MJ. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci USA 104: 19067-19072, 2007.
111. Nakagawa T, Kabuto M, Kubota T, Kodera T, and Sato K. Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors. Anticancer Res 19: 2963-2968, 1999. (Pubitemid 30042578)
112. Nakamura T, Cieplak P, Cho DH, Godzik A, and Lipton SA. S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration. Mitochondrion 10: 573-578, 2010.
113. Nakamura T, Wang L, Wong CC, Scott FL, Eckelman BP, Han X, Tzitzilonis C, Meng F, Gu Z, Holland EA, Clemente AT, Okamoto S, Salvesen GS, Riek R, Yates JR, 3rd, and Lipton SA. Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death. Mol Cell 39: 184-195, 2010.
114. Newington JT, Pitts A, Chien A, Arseneault R, Schubert D, and Cumming RC. Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. PLoS One 6: e19191, 2011.
115. Niatsetskaya Z, Basso M, Speer RE, McConoughey SJ, Coppola G, Ma TC, Ratan RR. HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: Therapeutic implications for Huntington's disease and Alzheimer's disease. Antioxid Redox Signal 12: 435-443, 2010.
116. O'Riordan MX, Bauler LD, Scott FL, and Duckett CS. Inhibitor of apoptosis proteins in eukaryotic evolution and development: A model of thematic conservation. Dev Cell 15: 497-508, 2008.
117. Osthus RC, Shim H, Kim S, Li Q, Reddy R, Mukherjee M, Xu Y, Wonsey D, Lee LA, and Dang CV. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem 275: 21797-21800, 2000. (Pubitemid 30621745)
118. Otera H and Mihara K. Molecular mechanisms and physiologic functions of mitochondrial dynamics. J Biochem 149: 241-251, 2011.
119. Palmer AM. The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease. J Neural Transm 106: 317-328, 1999. (Pubitemid 29196935)
120. Paola D, Domenicotti C, Nitti M, Vitali A, Borghi R, Cottalasso D, Zaccheo D, Odetti P, Strocchi P, Marinari UM, Tabaton M, and Pronzato MA. Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem Biophys Res Commun 268: 642-646, 2000. (Pubitemid 30119675)
121. Paris D, Patel N, Ganey NJ, Laporte V, Quadros A, and Mullan MJ. Anti-tumoral activity of a short decapeptide fragment of the Alzheimer's Abeta peptide. Int J Pept Res Ther 16: 23-30, 2010.
122. Paris D, Townsend K, Quadros A, Humphrey J, Sun J, Brem S, Wotoczek-Obadia M, DelleDonne A, Patel N, Obregon DF, Crescentini R, Abdullah L, Coppola D, Rojiani AM, Crawford F, Sebti SM, and Mullan M. Inhibition of angiogenesis by Abeta peptides. Angiogenesis 7: 75-85, 2004.
123. Pavlov PF, Wiehager B, Sakai J, Frykman S, Behbahani H, Winblad B, and Ankarcrona M. Mitochondrial gammasecretase participates in the metabolism of mitochondriaassociated amyloid precursor protein. FASEB J 25: 78-88, 2010.
124. Perluigi M, Di Domenico F, Giorgi A, Schinina ME, Coccia R, Cini C, Bellia F, Cambria MT, Cornelius C, Butterfield DA, and Calabrese V. Redox proteomics in aging rat brain: Involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process. J Neurosci Res 88: 3498-3507, 2010.
125. Prevarskaya N, Skryma R, and Shuba Y. Calcium in tumour metastasis: New roles for known actors. Nat Rev Cancer 11: 609-618, 2011.
126. Quintanilla RA, Matthews-Roberson TA, Dolan PJ, and Johnson GV. Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: Implications for the pathogenesis of Alzheimer disease. J Biol Chem 284: 18754-18766, 2009.
127. Rao KS, Hegde ML, Anitha S, Musicco M, Zucca FA, Turro NJ, and Zecca L. Amyloid beta and neuromelanin-Toxic or protective molecules? The cellular context makes the difference. Prog Neurobiol 78: 364-373, 2006. (Pubitemid 43850101)
128. Raule N, Sevini F, Santoro A, Altilia S, and Franceschi C. Association studies on human mitochondrial DNA: Methodological aspects and results in the most common agerelated diseases. Mitochondrion 7: 29-38, 2007. (Pubitemid 46351973)
129. Raurell I, Codina M, Casagolda D, Del Valle B, Baulida J, de Herreros AG, and Dunach M. Gamma-secretasedependent and-independent effects of presenilin1 on betacatenin. Tcf-4 transcriptional activity. PLoS One 3: e4080, 2008.
130. Reddy PH and Beal MF. Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev 49: 618-632, 2005. (Pubitemid 41546661)
131. Reed JC. Mechanisms of apoptosis avoidance in cancer. Curr Opin Oncol 11: 68-75, 1999. (Pubitemid 29082059)
132. Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, Turner DM, Coccia R, Markesbery WR, and Butterfield DA. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis 30: 107-120, 2008.
133. Reed TT, Pierce WM, Jr., Turner DM, Markesbery WR, and Butterfield DA. Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule. J Cell Mol Med 13: 2019-2029, 2009.
134. Ren F, Wu H, Lei Y, Zhang H, Liu R, Zhao Y, Chen X, Zeng D, Tong A, Chen L, Wei Y, and Huang C. Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma. Mol Cancer 9: 81, 2010.
135. Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H, Drose S, Brandt U, Savaskan E, Czech C, Gotz J, and Eckert A. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci USA 106: 20057-20062, 2009.
136. Roe CM, Behrens MI, Xiong C, Miller JP, and Morris JC. Alzheimer disease and cancer. Neurology 64: 895-898, 2005. (Pubitemid 40316334)
137. Roe CM, Fitzpatrick AL, Xiong C, Sieh W, Kuller L, Miller JP, Williams MM, Kopan R, Behrens MI, and Morris JC. Cancer linked to Alzheimer disease but not vascular dementia. Neurology 74: 106-112, 2009.
138. Rohn TT, Vyas V, Hernandez-Estrada T, Nichol KE, Christie LA, and Head E. Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2. J Neurosci 28: 3051-3059, 2008. (Pubitemid 351442294)
139. Ross JM, Oberg J, Brene S, Coppotelli G, Terzioglu M, Pernold K, Goiny M, Sitnikov R, Kehr J, Trifunovic A, Larsson NG, Hoffer BJ, and Olson L. High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratio. Proc Natl Acad Sci USA 107: 20087-20092, 2010.
140. Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, and Capaldi RA. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res 64: 985-993, 2004. (Pubitemid 38176901)
141. Rui Y, Tiwari P, Xie Z, and Zheng JQ. Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J Neurosci 26: 10480-10487, 2006. (Pubitemid 44564598)
142. Russell RL, Siedlak SL, Raina AK, Bautista JM, Smith MA, and Perry G. Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch Biochem Biophys 370: 236-239, 1999. (Pubitemid 29491430)
143. Sakono M and Zako T. Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J 277: 1348-1358, 2010.
144. Selkoe DJ. Clearing the brain's amyloid cobwebs. Neuron 32: 177-180, 2001. (Pubitemid 33030186)
145. Seppet E, Gruno M, Peetsalu A, Gizatullina Z, Nguyen HP, Vielhaber S, Wussling MH, Trumbeckaite S, Arandarcikaite O, Jerzembeck D, Sonnabend M, Jegorov K, Zierz S, Striggow F, and Gellerich FN. Mitochondria and energetic depression in cell pathophysiology. Int J Mol Sci 10: 2252-2303, 2009.
146. Setiawan VW, Chu LH, John EM, Ding YC, Ingles SA, Bernstein L, Press MF, Ursin G, Haiman CA, and Neuhausen SL. Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women. Cancer Genet Cytogenet 181: 16-19, 2008. (Pubitemid 351192037)
147. Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, Bryant K, Fritz LC, Galasko D, Thal LJ, et al. Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 361: 260-263, 1993. (Pubitemid 23034476)
148. Shalova IN, Cechalova K, Rehakova Z, Dimitrova P, Ognibene E, Caprioli A, Schmalhausen EV, Muronetz VI, and Saso L. Decrease of dehydrogenase activity of cerebral glyceraldehyde-3-phosphate dehydrogenase in different animal models of Alzheimer's disease. Biochim Biophys Acta 1770: 826-832, 2007. (Pubitemid 46420628)
149. Shi Q, Xu H, Yu H, Zhang N, Ye Y, Estevez AG, Deng H, and Gibson GE. Inactivation and reactivation of the mitochondrial alpha-ketoglutarate dehydrogenase complex. J Biol Chem 286: 17640-17648, 2011.
150. Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R, and Dang CV. c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth. Proc Natl Acad Sci USA 94: 6658-6663, 1997. (Pubitemid 27281920)
151. Shimizu S, Shinohara Y, and Tsujimoto Y. Bax and Bcl-xL independently regulate apoptotic changes of yeast mitochondria that require VDAC but not adenine nucleotide translocator. Oncogene 19: 4309-4318, 2000.
152. Sorensen L, Ekstrand M, Silva JP, Lindqvist E, Xu B, Rustin P, Olson L, and Larsson NG. Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice. J Neurosci 21: 8082-8090, 2001. (Pubitemid 32952765)
153. Soucek T, Cumming R, Dargusch R, Maher P, and Schubert D. The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39: 43-56, 2003. (Pubitemid 36830947)
154. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Bruck W, Jellinger K, and Lassmann H. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol 155: 1459-1466, 1999.
155. Stafford P and Chen-Quin EB. The pattern of natural selection in somatic cancer mutations of human mtDNA. J Hum Genet 55: 605-612, 2010.
156. Stahl A, Moberg P, Ytterberg J, Panfilov O, Brockenhuus Von Lowenhielm H, Nilsson F, and Glaser E. Isolation and identification of a novel mitochondrial metalloprotease (PreP) that degrades targeting presequences in plants. J Biol Chem 277: 41931-41939, 2002. (Pubitemid 35257506)
157. Stahl A, Nilsson S, Lundberg P, Bhushan S, Biverstahl H, Moberg P, Morisset M, Vener A, Maler L, Langel U, and Glaser E. Two novel targeting peptide degrading proteases, PrePs, in mitochondria and chloroplasts, so similar and still different. J Mol Biol 349: 847-860, 2005. (Pubitemid 40725958)
158. Sultana R, Boyd-Kimball D, Cai J, Pierce WM, Klein JB, Merchant M, and Butterfield DA. Proteomics analysis of the Alzheimer's disease hippocampal proteome. J Alzheimers Dis 11: 153-164, 2007. (Pubitemid 47010980)
159. Sultana R, Poon HF, Cai J, Pierce WM, Merchant M, Klein JB, Markesbery WR, and Butterfield DA. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 22: 76-87, 2006.
160. Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, Magistretti PJ, and Alberini CM. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 144: 810-823, 2011.
161. Takuma K, Yao J, Huang J, Xu H, Chen X, Luddy J, Trillat AC, Stern DM, Arancio O, and Yan SS. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J 19: 597-598, 2005. (Pubitemid 40471256)
162. Tanzi RE, Moir RD, and Wagner SL. Clearance of Alzheimer's Abeta peptide: The many roads to perdition. Neuron 43: 605-608, 2004. (Pubitemid 39179722)
163. Terni B, Boada J, Portero-Otin M, Pamplona R, and Ferrer I. Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer's disease pathology. Brain Pathol 20: 222-33, 2010.
164. Tesco G, Koh YH, and Tanzi RE. Caspase activation increases beta-amyloid generation independently of caspase cleavage of the beta-amyloid precursor protein (APP). J Biol Chem 278: 46074-46080, 2003. (Pubitemid 37432757)
165. Towle HC. Metabolic regulation of gene transcription in mammals. J Biol Chem 270: 23235-23238, 1995.
166. Trifunovic A, Hansson A, Wredenberg A, Rovio AT, Dufour E, Khvorostov I, Spelbrink JN, Wibom R, Jacobs HT, and Larsson NG. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci USA 102: 17993-17998, 2005. (Pubitemid 41798490)
167. Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, Serneels L, De Strooper B, Yu G, and Bezprozvanny I. Presenilins form ER Ca2 + leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126: 981-993, 2006. (Pubitemid 44310781)
168. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJ, 2nd, and Nikoskelainen EK. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242: 1427-1430, 1988. (Pubitemid 19008070)
169. van de Craen M, de Jonghe C, van den Brande I, Declercq W, van Gassen G, van Criekinge W, Vanderhoeven I, Fiers W, van Broeckhoven C, Hendriks L, and Vandenabeele P. Identification of caspases that cleave presenilin-1 and presenilin-Five presenilin-1 (PS1) mutations do not alter the sensitivity of PS1 to caspases. FEBS Lett 445: 149-154, 1999. (Pubitemid 29101551)
170. van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW, Schmechel DE, Murali Doraiswamy P, Gilbert JR, Haines JL, Vance JM, and Pericak-Vance MA. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365: 28-32, 2004. (Pubitemid 38952729)
171. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Jr., Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, and Vance JM. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72: 804-811, 2003. (Pubitemid 36403301)
172. Vander Heiden MG, Locasale JW, Swanson KD, Sharfi H, Heffron GJ, Amador-Noguez D, Christofk HR, Wagner G, Rabinowitz JD, Asara JM, and Cantley LC. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329: 1492-1499, 2010.
173. Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, and Zhu X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 29: 9090-9103, 2009.
174. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, and Zhu X. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 105: 19318-19323, 2008.
175. Vanhanen M and Soininen H. Glucose intolerance, cognitive impairment and Alzheimer's disease. Curr Opin Neurol 11: 673-677, 1998. (Pubitemid 28561204)
176. Warburg O. Ü ber den Stoffwechsel der Tumore. Spring, Berlin. Translated: The Metabolism of Tumors. Arnold Constable, Lindon, 1926.
177. Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, Parslow D, Armistead S, Lemire K, Orrell J, Teich J, Chomicz S, and Ferrick DA. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292: C125-136, 2007. (Pubitemid 46115126)
178. Xie Z, Dong Y, Maeda U, Moir RD, Xia W, Culley DJ, Crosby G, and Tanzi RE. The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J Neurosci 27: 1247-1254, 2007.
179. Yakes FM and Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 94: 514-519, 1997. (Pubitemid 27053665)
180. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, and Wang X. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997. (Pubitemid 27097312)
181. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, and Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106: 14670-14675, 2009.
182. Zanna C, Ghelli A, Porcelli AM, Karbowski M, Youle RJ, Schimpf S, Wissinger B, Pinti M, Cossarizza A, Vidoni S, Valentino ML, Rugolo M, and Carelli V. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation andmitochondrial fusion. Brain 131: 352-367, 2008. (Pubitemid 351197625)
183. Zhao H, Zhu J, Cui K, Xu X, O'Brien M, Wong KK, Kesari S, Xia W, and Wong ST. Bioluminescence imaging reveals inhibition of tumor cell proliferation by Alzheimer's amyloid beta protein. Cancer Cell Int 9: 15, 2009.